- Home
- TVA vs AVTX Comparison
TVA vs AVTX Comparison
Compare TVA & AVTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TVA
- AVTX
- Stock Information
- Founded
- TVA 2024
- AVTX 2011
- Country
- TVA United States
- AVTX United States
- Employees
- TVA N/A
- AVTX N/A
- Industry
- TVA
- AVTX Biotechnology: Pharmaceutical Preparations
- Sector
- TVA
- AVTX Health Care
- Exchange
- TVA Nasdaq
- AVTX Nasdaq
- Market Cap
- TVA 303.9M
- AVTX 248.3M
- IPO Year
- TVA 2025
- AVTX 2015
- Fundamental
- Price
- TVA $11.02
- AVTX $18.04
- Analyst Decision
- TVA
- AVTX Strong Buy
- Analyst Count
- TVA 0
- AVTX 9
- Target Price
- TVA N/A
- AVTX $30.14
- AVG Volume (30 Days)
- TVA 445.1K
- AVTX 386.5K
- Earning Date
- TVA 01-01-0001
- AVTX 11-07-2025
- Dividend Yield
- TVA N/A
- AVTX N/A
- EPS Growth
- TVA N/A
- AVTX N/A
- EPS
- TVA N/A
- AVTX N/A
- Revenue
- TVA N/A
- AVTX $441,000.00
- Revenue This Year
- TVA N/A
- AVTX N/A
- Revenue Next Year
- TVA N/A
- AVTX N/A
- P/E Ratio
- TVA N/A
- AVTX N/A
- Revenue Growth
- TVA N/A
- AVTX N/A
- 52 Week Low
- TVA $9.98
- AVTX $3.39
- 52 Week High
- TVA $12.27
- AVTX $19.41
- Technical
- Relative Strength Index (RSI)
- TVA N/A
- AVTX 68.17
- Support Level
- TVA N/A
- AVTX $16.77
- Resistance Level
- TVA N/A
- AVTX $19.01
- Average True Range (ATR)
- TVA 0.00
- AVTX 1.54
- MACD
- TVA 0.00
- AVTX 0.20
- Stochastic Oscillator
- TVA 0.00
- AVTX 78.03
About TVA Texas Ventures Acquisition III Corp Class A Ordinary Share
Texas Ventures Acquisition III Corp is a blank check company.
About AVTX Avalo Therapeutics Inc.
Avalo Therapeutics Inc is a clinical-stage biotechnology company focused on the treatment of immune dysregulation. The company's asset is AVTX-009, an anti-IL-1B monoclonal antibody ("mAb"), targeting inflammatory diseases. Avalo's pipeline also includes quisovalimab (anti-LIGHT mAb) and AVTX-008 (BTLA agonist fusion protein).